Diagnosis of Wilson Disease in Young Children: Molecular Genetic Testing and a Paradigm Shift from the Laboratory Diagnosis.
10.5223/pghn.2012.15.4.197
- Author:
Jeong Kee SEO
1
Author Information
1. Division of Pediatric Gastroenterology, Hepatology and Nutrition, Department of Pediatrics, College of Medicine, Seoul National University, Seoul, Korea. jkseo@snu.ac.kr
- Publication Type:Review
- Keywords:
Wilson disease;
ATP7B;
Genetic diagnosis;
Mutation;
Child
- MeSH:
Bile;
Brain;
Ceruloplasmin;
Child;
Clinical Laboratory Techniques;
Copper;
Cornea;
Discrimination (Psychology);
Early Diagnosis;
Genetic Testing;
Haplotypes;
Hepatocytes;
Hepatolenticular Degeneration;
Heterozygote;
Humans;
Liver;
Mass Screening;
Molecular Biology;
Sequence Analysis, DNA;
Siblings
- From:Pediatric Gastroenterology, Hepatology & Nutrition
2012;15(4):197-209
- CountryRepublic of Korea
- Language:English
-
Abstract:
Wilson disease (WD) is an autosomal recessive disorder of copper metabolism that results in accumulation of copper primarily in the liver, brain and cornea. Mutations in the WD gene, ATP7B, cause failure of copper excretion from hepatocyte into bile and a defective synthesis of ceruloplasmin. More than 500 mutations are now recognized, scattered throughout the ATP7B gene. Since WD has protean clinical presentations, awareness of WD in clinical practice is important for the early diagnosis and prevention of accumulated copper toxicity. Molecular genetic testing is playing an increasingly important role in the diagnosis of WD in uncertain cases and family screening. Siblings should be screened for WD once an index case has been diagnosed. Discrimination of heterozygotes from asymptomatic patients is essential to avoid inappropriate lifelong therapy for heterozygotes. Genetic testing, either by haplotype analysis or by mutation analysis, is the only definite solution for differentiating heterozygote carriers from affected asymptomatic patients. Routine genetic testing, because of the multitude of documented mutations, has been thought to be impractical until recently. However, genetic testing is now being more actively applied to the diagnosis of WD, particularly in young children in whom conventional biochemical diagnosis has much limitation and only genetic testing is able to confirm WD. Because advancement of modern biochemical technology now allows more rapid, easier, and less expensive mutation detection, direct DNA sequencing could be actively considered as the primary mode of diagnostic investigation rather than a supplementary test to the conventional biochemical tests. This review will focus on the recent advancement of molecular genetics and genetic diagnosis of WD in very young children on the basis of research data of the Seoul National University Children's Hospital and recent literature.
